Introduction
============

Joubert syndrome (JS) and related cerebellar disorders (JSRDs) are rare autosomal recessive disorders characterized by multiple symptoms, including developmental delay, mental retardation, and hypotonia, as well as a defining midbrain--hindbrain junction malformation called the molar tooth sign ([@bib30]). Seven JS/JSRD genes are cloned: *AHI1*, *CEP290*, *NPHP1*, *MKS3*, *RPGRIP1L*, *ARL13B*, and *CC2D2A* ([@bib16]; [@bib20]; [@bib37]; [@bib12]; [@bib44]; [@bib51],[@bib52]; [@bib1]; [@bib10]; [@bib22]). Because most of these genes encode ciliary proteins, are required for cilium structure/function, and cause ciliary disease symptoms (cystic kidneys, retinitis pigmentosa, etc.), JSRDs are thought to be caused by defects in cilia.

Cilia extend from most eukaryotic cell surfaces, serving motility and sensory functions such as chemo-, photo-, and mechanotransduction, as well as facilitating developmental signaling (e.g., Shh; [@bib13]; [@bib18]; [@bib42]). Cilia are built by intraflagellar transport (IFT), a kinesin-2-- and cytoplasmic dynein--driven bidirectional movement of protein complexes between the ciliary base and tip which traffics ciliary protein cargoes and turnover products ([@bib43]; [@bib40], [@bib41]; [@bib7]). Associated with the motor machinery and essential for IFT is the IFT particle, consisting of two subcomplexes, IFT-A (\>6 proteins) and IFT-B (\>12 proteins; [@bib43]; [@bib7]). Discoveries linking IFT defects to developmental (e.g., Shh) signaling abnormalities highlight the importance of IFT for ciliary signaling and suggest that mistransport of ciliary proteins contributes to the development of ciliopathy symptoms ([@bib4]; [@bib18]).

*Caenorhabditis elegans* is an established model organism for investigating cilium biogenesis/function, IFT, and ciliopathy gene function ([@bib28]). In worms, cilia extend from the distal dendrite tips of sensory neurons, forming sensory structures that are typically environmentally exposed. IFT can be directly visualized in live worms, and mutant alleles and markers are available for most IFT proteins. In *C. elegans*, IFT is most extensively studied in rod-shaped amphid channel cilia, consisting of a middle segment (MS; nine outer doublet microtubules \[MTs\]) and distal segment (DS; nine outer singlet MTs). Two kinesin-2 motors (heterotrimeric kinesin-II and homodimeric OSM-3) act cooperatively to drive MS anterograde IFT at ∼0.7 µms^−1^ ([@bib33]; [@bib47]; [@bib34]; [@bib36]). At MS tips, kinesin-II disengages, and OSM-3 completes DS IFT at ∼1.2--1.3 µms^−1^. Although IFT regulation is poorly understood in any organism, *C. elegans* BBS (Bardet-Biedl syndrome) proteins coordinate the association of kinesin-2 motors and IFT-A/B complexes ([@bib34], [@bib35]), DYF-5 restricts kinesin-II to MSs and regulates OSM-3--kinesin translocation rates ([@bib9]), and NPH (nephronophthisis) proteins differentially regulate ciliary entry of IFT proteins and OSM-6/IFT52 translocation rates ([@bib29]). Regarding IFT cargoes, the ciliary transmembrane protein OSM-9 undergoes IFT-like motility, and PKD-2 (polycystin 2) ciliary abundance is IFT regulated ([@bib41]; [@bib2]).

To identify new genes with ciliary functions, including ciliopathy genes, one approach has been to select candidates from published datasets enriched for cilia-related genes and proteins. These ciliomes have been identified in different systems using many experimental approaches ([@bib27]). For example, in *C. elegans*, bioinformatic screening for binding sites (X-boxes) of the ciliogenic transcription factor DAF-19, together with identifying genes expressed only in ciliated cells, uncovered new IFT-related components ([@bib6]; [@bib27]) and aided in cloning at least one new ciliopathy gene ([@bib19]). One promising candidate ciliogenic gene to emerge from ciliomics is *C. elegans arl-13* (Y37E3.5), an X-box--containing gene expressed only in ciliated cells and encoding a ciliary protein ([@bib6]). Vertebrate ARL-13 (Arl13b) also localizes to cilia and is required for ciliogenesis and Shh signaling ([@bib48]; [@bib11]; [@bib25]; [@bib17]). Recently, mutations in *Arl13b* have been found in JS patients, thereby confirming *Arl13b* as a ciliopathy gene ([@bib10]). ARL-13/Arl13b is an Arf-like member of the Ras superfamily of small GTPases implicated in vesicle trafficking, cellular differentiation, cell movement, and cytoskeletal processes. Indeed, ciliary functions are known for other small G proteins such as ARL3, ARL6/BBS3, and RAB8, indicating that multiple GTPases serve cilia-related functions ([@bib14]; [@bib19]; [@bib31]; [@bib53]).

Although Arl13b is known to function in ciliogenesis and vertebrate Shh signaling, the ciliary and molecular basis of these functions remains unclear. In this study, we used *C. elegans* and mammalian tissue culture models to show that ARL-13/Arl13b is a ciliary membrane--associated protein, which in certain ciliary subtypes is restricted to the proximal ciliary region. Furthermore, we find that *C. elegans* ARL-13 maintains cilium structure/morphology and provide evidence that ARL-13 is required for ciliary transmembrane protein localizations/abundance and the stabilization of anterograde IFT assemblies. From these data, we propose that ARL-13/Arl13b functions at ciliary membranes to stabilize ciliary protein transport processes.

Results
=======

ARL-13 is homologous to JS-associated Arl13b
--------------------------------------------

BLAST analyses identified ARL-13 (Y37E3.5) sequence homologues in mice (Arl13b), zebrafish (Scorpion), *Xenopus laevis*, and *Chlamydomonas reinhardtii*, each possessing an extended tail (100--300 residues) C-terminal to the GTPase domain ([Fig. S1 A](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1)). In contrast, the top hits in *Drosophila melanogaster* and *Tetrahymena thermophila* returned lower BLAST scores and lacked extended tails, indicating that ARL-13 homologues are not present in all ciliates (Fig. S1 A). Sequence alignment showed that all ARL-13 homologues contain an N-terminal palmitoylation (Pal) modification motif (not found in most G proteins), possess the three residues (R79, W82, and R200) mutated in patients with Arl13b-associated JS ([@bib10]), and lack the switch two Gln residue critical for GTPase activity in most Arl/Arfs (Fig. S1 B). Together with previous findings that nematode ARL-13 and vertebrate Arl13b localize exclusively to cilia ([@bib6]; [@bib11]; [@bib10]; [@bib17]), in addition to being required for proper cilium formation (see [Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}; [@bib48]; [@bib11]; [@bib25]; [@bib17]), we conclude that ARL-13 is evolutionarily conserved and represents the orthologue of JS-associated Arl13b.

ARL-13/Arl13b is enriched in proximal regions of *C. elegans* and mammalian cilia
---------------------------------------------------------------------------------

Although *C. elegans* ARL-13 was previously shown to localize to cilia ([@bib6]), published images suggest that ARL-13 may not localize along the entire axoneme. To assess this further, we made new transgenic lines expressing a rescuing *arl-13::gfp* construct. Unlike GFP-tagged IFT proteins, which extended 6--8 µm from the ciliary base, ARL-13::GFP signals in amphid/phasmid cilia extended only ∼3--4 µm ([Fig. 1 A](#fig1){ref-type="fig"}). A similar restricted proximal ciliary localization was also observed in male tail ray neuronal cilia ([Fig. 1 A](#fig1){ref-type="fig"}). In contrast, although enriched in the proximal region of AWB cilia, ARL-13::GFP localized to the entire AWB cilium, including distal fan membranes ([Fig. 1 A](#fig1){ref-type="fig"}), indicating that ARL-13 is not excluded from the distal regions of all nematode cilia. Similarly, endogenous mammalian Arl13b localized predominantly to proximal ciliary regions of MDCKII cilia ([Fig. 1 B](#fig1){ref-type="fig"}), although in RPE1 cells, Arl13b localizes to the entire axoneme ([@bib25]). Together, these findings show that in various ciliary subtypes, ARL-13/Arl13b is highly enriched in proximal ciliary regions, with little or no detectable protein in distal regions. Finally, using time-lapse videomicroscopy, no ciliary translocation was found for *C. elegans* ARL-13::GFP, indicating that ARL-13 does not undergo IFT ([Fig. 1 A](#fig1){ref-type="fig"}).

![**ARL-13/Arl13b is enriched in proximal regions of ciliary axonemes.** (A) ARL-13::GFP localizes almost exclusively to the proximal region (MSs; m) of amphid/phasmid cilia and male tail ray cilia. Although localizing to all regions of AWB cilia, ARL-13 is enriched in proximal regions and observed at the membrane of distal fans (arrow). IFT markers (CHE-2 and -11) label amphid/phasmid channel MSs and DSs (d) and RnA/B male tail ray cilia. Kymographs, from time-lapse videos, show no IFT movement for ARL-13::GFP. Arrowheads indicate RnA/B cilia, and insets show high magnification images of RnA/B cilia. (B) Arl13b is enriched in the proximal region of MDCKII cilia. Images after immunostaining for endogenous Arl13b, acetylated α-tubulin (ciliary axoneme), and γ-tubulin (basal body) are shown. Bars: (A, left and right) 3 µm; (A, middle) 10 µm; (A, insets) 1 µm; (B) 5 µm.](JCB_200908133_RGB_Fig1){#fig1}

ARL-13/Arl13b associates with the ciliary membrane via palmitoyl anchors
------------------------------------------------------------------------

CSS-Palm 2.0 software ([@bib54]) identified a putative N-terminal Pal modification motif in ARL-13 and Arl13b that may anchor this G protein to ciliary membranes (Fig. S1 B). To investigate this hypothesis, we expressed in *C. elegans* two Pal variants of ARL-13 (GFP tagged): delPal (deletion of C12--C15) and rPal (replacement of C12--C15 with ASAS). Both proteins were mislocalized, displaying only weak ciliary signals and abnormal strong cytosolic (diffuse) signals in cell bodies, dendrites, and axons ([Fig. 2 A](#fig2){ref-type="fig"}). Quantification of signals showed that although \>90% of ARL-13(wild type \[WT\]) was ciliary, only 10--20% of the Pal variant signals were ciliary ([Fig. 2 A](#fig2){ref-type="fig"}). The diffuse Pal variant localizations suggest loss of membrane tethering, and in support of this notion, a C-terminal ARL-13 truncation variant (del203--370; intact Pal motif) retained membrane associations, although delocalized in cell bodies and dendrites ([Fig. 2 A](#fig2){ref-type="fig"}, arrows). Similarly, in mammalian cells, Arl13b(C8S/C9S) was also mislocalized, with little signal in cilia and diffuse extra-ciliary signals indicative of membrane dissociation ([Fig. 2 B](#fig2){ref-type="fig"}). Subcellular fractionation analysis of 293T cells transfected with HsArl13b::Flag (WT or variants) revealed that Arl13b(WT) pelleted at 20,000 *g* together with the Na^+^/K^+^ ATPase membrane protein ([Fig. 2 C](#fig2){ref-type="fig"}). In contrast, C8S/C9S and 20--428 Pal variants cofractionated with the cytosolic protein calpain even after 200,000 *g* spins ([Fig. 2 C](#fig2){ref-type="fig"}). Consistent with these data, a C-terminal truncation variant (1--357), which retains the Pal motif, fractionated in an identical manner to Arl13b(WT) ([Fig. 2 C](#fig2){ref-type="fig"}). These findings show that Pal motif disruption alters the subcellular fractionation of Arl13b, shifting it from membrane protein--associated fractions to cytosolic fractions. Finally, \[^3^H\]palmitic acid metabolic labeling of 293T cells transfected with GFP-tagged Arl13b (WT or C8S/C9S variant) revealed that Arl13b(WT)::GFP but not Arl13b(C8S/C9S)::GFP incorporated \[^3^H\]palmitate ([Fig. 2 D](#fig2){ref-type="fig"}, arrow). Together, these data indicate that ARL-13/Arl13b associates with ciliary membranes via palmitoyl anchors.

![**ARL-13/Arl13b associates with ciliary membranes via palmitoyl anchors.** (A) N-terminal Pal motif ARL-13 variants (delPal and rPal) fail to localize to amphid (head) and phasmid (tail) cilia (c) and diffusely mislocalize in cell bodies (cb) and dendrites (d). C-terminal deletion ARL-13(del203--370) is also mislocalized, but membrane associations are maintained (arrows). Insets show high magnification images of PHA/B cilia. (B) HsArl13b ciliary localization requires an N-terminal Pal motif. Ciliated RPE1 cells transfected with GFP-tagged Arl13b(WT) or a C8S/C9S variant and costained for ciliary axonemes using acetylated α-tubulin antibody are shown. Merged images show that Arl13b(C8S/C9S) is highly diffuse and nonmembrane associated, with weak signals in cilia. The boxed regions are shown at high magnification in the insets. Dashed lines outline the cell. (C) Loss of Pal motif shifts HsArl13b to cytosolic fractions. A subcellular fractionation scheme for Flag-tagged Arl13b (WT and variants) transiently expressed in 293T cells is shown. Supernatants (Sup.) and pellets (Pell) were probed for Arl13b::Flag using Western blotting and an anti-Flag antibody. Calpain and Na^+^/K^+^ ATPase proteins mark cytosol and membrane fractions, respectively. Arl13b(WT) and Arl13b(1--357) pellet with Na^+^/K^+^ ATPase membrane proteins after 20,000 *g* spins, whereas Arl13b(C8S/C9S) remains in calpain-enriched cytosolic supernatants even after 200,000 *g* spins. (D) Arl13b is palmitoylated in 293T cells. 293T cells transiently transfected with GFP-tagged Arl13b(WT) or Arl13b(C8S/C9S) were metabolically labeled with \[^3^H\]palmitate, and proteins were separated by SDS-PAGE. The top panel shows a fluorograph; the bottom panel shows a Western blot with anti-GFP antibody. The arrow indicates palmitoylated Arl13b-GFP, and the asterisk indicates an unknown endogenous palmitoylated protein. Bars: (A) 5 µm; (B) 10 µm.](JCB_200908133_RGB_Fig2){#fig2}

*arl-13* is required for normal sensory cilium morphology, ultrastructure, and function
---------------------------------------------------------------------------------------

Although Arl13b is linked to cilium biogenesis and Shh signaling, the molecular basis of these functions is poorly understood ([@bib11]; [@bib10]; [@bib25]; [@bib17]). In this study, we investigated *C. elegans* ARL-13 function using the *tm2322* in-frame deletion, which is predicted to encode an ARL-13 protein lacking aa 169--342 ([Fig. 3 A](#fig3){ref-type="fig"}). Using a *gfp*-tagged transgene, we found that although some ARL-13(tm2322) accumulated beneath cilia and in dendrites/cell bodies, most protein still resided in cilia ([Fig. 3 B](#fig3){ref-type="fig"}), indicating that *tm2322* is not likely a null mutation but instead encodes a protein with residual/altered ciliary functions.

![***C. elegans arl-13* mutants possess defective cilium structure, morphology, and functions.** (A) *arl-13* gene schematic, showing genomic position of in-frame *tm2322* deletion. (B) *tm2322* encodes a ciliary ARL-13 protein. Fluorescence images of amphid/phasmid channel cilia in worms expressing *arl-13(tm2322)::gfp* are shown. GFP signals are restricted to MSs (m) and excluded from DSs (d). Some abnormal accumulations are found beneath cilia (arrowheads). (C) *tm2322* mutants are dye-filling (Dyf) defective. Merged differential interference contrast (DIC)--fluorescence images after a DiI uptake assay are shown. Dye uptake into amphid (head) and phasmid (tail) neuron cell bodies (denoted by brackets) is strongly reduced in *tm2322* mutants and weakly reduced in WT animals expressing *arl-13(delPal)::gfp* but restored in *tm2322* animals expressing *arl-13(WT)::gfp*. (D) Cilium morphologies are defective in *tm2322* worms. Fluorescence images of cilia from N2 and *tm2322* animals expressing ciliated cell--specific transcriptional GFP markers *srb-6p::gfp* (PHA/B), *gcy-5p::gfp* (ASER), *str-1p::gfp* (AWB), *str-2p::gfp* (AWC), and *gpa-6p::gfp* (AWA) are shown. All images are similarly orientated, with ciliary base denoted (asterisks). Arrowheads indicate morphology defects such as kinks (ASER), bulges (PHA/B and AWA), curls (AWB,) and ectopic projections (AWC). (E) *tm2322* mutants are chemosensory defective. Indices obtained from 30- and 60-min chemoattraction assays toward isoamyl alcohol for *tm2322*, N2, and *osm-5(p802)* worms are shown. Assay numbers are shown in parentheses. Error bars indicate SEM. Bars: (B and D) 3 µm; (C) 10 µm.](JCB_200908133R_RGB_Fig3){#fig3}

First, we found that *tm2322* mutants were partially dye-filling defective (Dyf), with 40% of phasmids failing to incorporate dye (DiI), and although amphid neurons were less affected, dye uptake was frequently reduced or absent ([Fig. 3 C](#fig3){ref-type="fig"}). Transgenic expression of *arl-13(WT)::gfp* in *tm2322* animals rescued the Dyf phenotype ([Fig. 3 C](#fig3){ref-type="fig"}). Interestingly, expression of *arl-13\[delC12--C15\]::gfp* (delPal variant) in WT worms caused a mild Dyf phenotype, suggesting a weak dominant-negative phenotype ([Fig. 3 C](#fig3){ref-type="fig"}). Consistent with the Dyf phenotype, direct visualization of *tm2322* cilia using transcriptional GFP markers revealed defective cilium shapes ([Fig. 3 D](#fig3){ref-type="fig"}). PHA/B cilia were often kinked, possessed axonemal bulges, and frequently failed to coalesce ([Fig. 3 D](#fig3){ref-type="fig"}). AWA cilia typically lacked the characteristic multibranched structure and possessed abnormal bulbous distal tips, and although less affected, ASER, AWB and AWC cilia were often kinked (ASER) or curly (ASER and AWB) or possessed ectopic projections (AWC; [Fig. 3 D](#fig3){ref-type="fig"}). Next, using transmission electron microscopy, we examined *tm2322* amphid channel cilium ultrastructure. Similar to WT cilia, *tm2322* cilia were segmented, possessing DSs, MSs, and transition zone and transition fiber segments ([Fig. 4](#fig4){ref-type="fig"}). However, axonemes were often missing in *arl-13* animals, indicating that some cilia were truncated, missing, and/or misdirected away from the pore ([Fig. 4 C](#fig4){ref-type="fig"}). Also, *arl-13* mutant cilia frequently exhibited MS defects, including enlarged axonemes, and accumulation of amorphous electron-dense matrix material, which in some cases appeared within vesicle-type structures ([Fig. 4, J, M, N, R, S, and U](#fig4){ref-type="fig"}). These MS enlargements may correspond to the axonemal bulges described in [Fig. 3 D](#fig3){ref-type="fig"}. In addition, outer doublet MTs were frequently misplaced/misaligned ([Fig. 4, J, N, O, S, and U](#fig4){ref-type="fig"}, arrows) and of incorrect number (not depicted), and there is evidence of an increased frequency of unzipped MTs ([Fig. 4, J, O, and U](#fig4){ref-type="fig"}). Consistent with cilium structure/ultrastructure defects, *tm2322* mutants displayed abrogated isoamyl alcohol chemosensation, a behavior mediated by AWA/AWC cilia ([Fig. 3 E](#fig3){ref-type="fig"}).

![***arl-13(tm2322)* mutant cilia possess ultrastructural defects.** Transmission electron microscopy serial cross sections of amphid pore from N2 and *tm2322* worms. (A--E) Distal pore showing 10 axonemes in N2 worms (A and B) but only 4 axonemes in *tm2322* mutants (C--E). (F--J) 2 µm proximal to A--E (through MSs) showing axonemes still missing in *tm2322* worms (H). Also, abnormal accumulation of electron-dense material (J, arrowhead) and unzipping of MTs (J, arrow) are observed. (K--O) 3 µm proximal to A--E (through MSs) showing most ciliary axonemes are present in *tm2322* mutants (M). Further abnormal axonemal accumulations of amorphous electron-dense material (N, arrowheads) and missing, misplaced, and unzipped doublet MTs (N and O, arrows) are also shown. (P--T) 5 µm proximal to A and B, through MSs, transition zones, and transitional fibers. Some *tm2322* cilia are abnormally enlarged (R and S), filled with electron-dense material that is amorphous, or contained within vesicle-type structures (R and S). (S) Arrowheads indicate amorphous and vesicular-like accumulations. Transition zones appear normal (T). (U) Schematics of amphid channel cilia from N2 and *tm2322* mutants, showing the major ultrastructural defects observed. tz, transition zone. Bars, 200 µm.](JCB_200908133_RGB_Fig4){#fig4}

Together, these data corroborate and extend previous vertebrate Arl13b data ([@bib11]; [@bib10]; [@bib25]; [@bib17]) by showing that *C. elegans arl-13* is required for normal cilium morphology, ultrastructure, and function. Particularly intriguing is that *arl-13* mutant cilia possessed enlarged MS diameters and axonemal accumulations of dense matrix--filled vesicle structures, as well as subtle MT abnormalities; these findings could suggest roles for ARL-13 in ciliary membrane maintenance/turnover and/or axonemal MT stability/integrity.

Ciliary transmembrane protein localizations are disrupted in *arl-13* mutants
-----------------------------------------------------------------------------

To further investigate potential ciliary membrane defects, we examined the ciliary localizations of chemo- or mechanosensory transmembrane proteins (PKD-2, ODR-10, TAX-2, and OSM-9) in *tm2322* worms, and in all cases, defects were found ([Fig. 5, A and B](#fig5){ref-type="fig"}). Specifically, OSM-9::GFP accumulated in the distal dendrites of 55% of *arl-13* mutants (*n* = 55), whereas ODR-10::GFP and TAX-2::GFP accumulated in the cilium and/or distal dendrites of 90% (*n* = 69) and 51% (*n* = 27) of animals, respectively. In WT animals, no such accumulations were observed for OSM-9::GFP, and only 9% of animals displayed weak ODR-10 ciliary accumulations. We also noticed that the ciliary abundance of PKD-2 was higher in *arl-13* mutants compared with WT animals, with the former possessing five times more PKD-2 than the latter ([Fig. 5, B and C](#fig5){ref-type="fig"}). Conversely, the intensity of cell body PKD-2 signals in *arl-13* worms was 50% less than that of WT worms ([Fig. 5 C](#fig5){ref-type="fig"}). This was not the result of alterations in *pkd-2::gfp* expression levels because the combined intensity of cell body and cilium signals was similar (unpublished data). Consistent with weak dominant-negative effects by *arl-13(delPal)* transgene overexpression on dye filling ([Fig. 3 C](#fig3){ref-type="fig"}), PKD-2 ciliary abundance was not increased in these animals ([Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1)). Together, these data show that ARL-13 is required for proper targeting/retention of ciliary transmembrane proteins.

![**Ciliary transmembrane protein localization is disrupted in *arl-13(tm2322)* mutants.** (A and B) Representative fluorescence images of the distal head region (nose) of worms expressing *gfp*-tagged ODR-10, OSM-9, TAX-2, and PKD-2 are shown. In *tm2322* mutants, abnormal accumulations (arrowheads) are found in ciliary axonemes (ODR-10), near the ciliary base (ODR-10 and TAX-2; asterisks), or within the distal dendrite (OSM-9; arrowhead). In *tm2322* mutants, PKD-2::GFP ciliary abundance is elevated in CEM and RnB cells, with cell body levels reduced (shown for CEMs). c, cilium. (C) Analysis of PKD-2::GFP ciliary abundance in CEM cells. The ratio of PKD-2::GFP signal intensities in individual CEM cilia (F~cilia~) and individual CEM cell bodies (F~cell\ body~) is shown. All images were captured and analyzed using identical settings. The number of cilia analyzed is shown in parentheses. Error bars indicate SEM. Bars: (A and B \[first and second columns\]) 2 µm; (B, third and fourth columns) 10 µm.](JCB_200908133R_GS_Fig5){#fig5}

IFT is disrupted in *arl-13* mutants
------------------------------------

Because IFT-related gene mutants also possess defects in the ciliary localizations of transmembrane proteins ([@bib2]; [@bib49]), we hypothesized that IFT may be disrupted in *arl-13* mutants. Using GFP markers, we found that IFT proteins localized normally at the ciliary base and axoneme of *arl-13* mutants ([Fig. 6 A](#fig6){ref-type="fig"}). However, cilium structure/morphology in certain transgenic *tm2322* strains appeared more disrupted than other transgenic strains; for example, in *arl-13* worms overexpressing *che-13::gfp*, *osm-6::gfp*, or *bbs-7/8::gfp*, cilia were more highly disorganized and dispersed than other transgenic strains ([Fig. 6 A](#fig6){ref-type="fig"}), suggesting that overexpression of certain IFT transgenes enhances the cilium defects of *tm2322* mutants. Using dye filling to assess this further, *arl-13* mutants expressing *gfp*-tagged *kap-1*, *osm-6*, *bbs-7*, *bbs-8*, *dyf-1*, or *che-13* were found to possess stronger Dyf phenotypes (SynDyf) than nontransgenic *arl-13* worms or *arl-13* mutants expressing *gfp*-tagged *osm-3*, *che-2*, or *che-11* ([Fig. 6 B](#fig6){ref-type="fig"}). Together, these findings indicate that IFT transgene overexpression is toxic to *tm2322* worms, causing enhanced cilium structure defects.

![**IFT transgene overexpression enhances the structure/morphology defects of *tm2322* mutant cilia.** (A) Fluorescence images of amphid/phasmid cilia in N2 and *arl-13(tm2322)* animals expressing *gfp*-tagged IFT transgenes show that IFT proteins localize normally to ciliary axonemes (ax) and accumulate normally at ciliary bases (asterisks) in *tm2322* worms. In *tm2322* mutants overexpressing *che-13::gfp*, *osm-6::gfp*, and *bbs-7/8::gfp*, amphid/phasmid cilia morphologies are more severely defective than other transgenic strains. Enhanced defects include missing DS staining (open arrowhead), axonemes that are less tightly bunched and highly disorganized (closed arrowheads; open arrow), and increased frequency of large axonemal bulges (closed arrows). (B) *arl-13* animals overexpressing *osm-3::gfp*, *che-2::gfp*, *che-11::gfp*, and *che-13::mCherry(low expression level)* display similar levels of DiI incorporation to nontransgenic controls (arrowheads indicate dye uptake in cell bodies). However, *tm2322* mutants overexpressing *che-13::gfp*, *osm-6::gfp*, *bbs-7::gfp*, *dyf-1::gfp*, and *che-13::mCherry(high expression level)* are SynDyf, failing to take dye. Merged DIC--fluorescence images (head) after a DiI uptake assay are shown. Bars: (A) 2 µm; (B) 10 µm.](JCB_200908133_RGB_Fig6){#fig6}

Next, we used IFT motility assays to measure anterograde IFT in *arl-13* worms. Like previous studies ([@bib47]; [@bib9]; [@bib29]), IFT occurred along WT amphid channel cilium MSs at a mean speed of 0.71 µms^−1^ (0.67--0.75 µms^−1^) and along DSs at a mean speed of 1.15 µms^−1^ (1.11--1.19 µms^−1^; [Fig. S3](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1) and [Table I](#tbl1){ref-type="table"}). These rates are consistent with the cooperative model of kinesin-II (slow motor; 0.5 µms^−1^) and OSM-3 (fast motor; 1.3 µms^−1^) driving MS IFT at intermediate speeds (0.7 µms^−1^), with OSM-3 alone driving DS transport at fast speeds (1.3 µms^−1^; [@bib47]). However, in *tm2322* strains expressing *gfp*-tagged *kap-1*, *osm-6*, *che-13*, *dyf-2*, and *bbs-7* (all SynDyf except the *dyf-2*--expressing strain), MS IFT proceeded at a mean speed of 0.51 µms^−1^ (0.47--0.55 µms^−1^), suggesting transport by kinesin-II alone (Fig. S3, [Table I](#tbl1){ref-type="table"}, and [Videos 1 and 2](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1)). Surprisingly, in *tm2322* worms expressing *gfp*-tagged *osm-3*, *dyf-1*, *che-2*, *che-11*, and *ifta-1* (all non-SynDyf except the *dyf-1*--expressing strain), MS IFT proceeded at mean speeds of ∼0.71 µms^−1^ (0.66--0.76 µms^−1^), which is identical to WT speeds and indicates normal trafficking by OSM-3 and kinesin-II (Fig. S3 and [Table I](#tbl1){ref-type="table"}). Consistent with the latter, CHE-11::GFP slowed to ∼0.5 µms^−1^ in *arl-13;osm-3* worms ([Table I](#tbl1){ref-type="table"}). However, although mean MS speeds were normal, OSM-3::GFP MS rate profiles showed more fast particles (\>0.9 µm/s) in *arl-13* mutants compared with WT worms (Fig. S3), suggesting that some OSM-3 is uncoupled from kinesin-II. Similarly, CHE-11::GFP rate profiles showed increased numbers of slow-moving particles (Fig. S3), suggesting some CHE-11 may be moving with an uncoupled kinesin-II pool.

###### 

Anterograde IFT velocities in *arl-13* mutants

  IFT Protein             Strain            MS          DS                                         
  ----------------------- ----------------- ----------- -------- ------------ ----------- -------- ------------
                                            *µms^−1^*                         *µms^−1^*            
  OSM-3::GFP              N2                0.70/0.12   258/18                1.17/0.21   63/6     
  OSM-3::GFP              *arl-13*          0.76/0.29   210/17   P = 0.001    0.98/0.26   199/18   P \< 0.001
  OSM-3::GFP              *klp-11*          1.17/0.16   155/12   P \< 0.001   1.21/0.20   76/8     P = 0.09
  OSM-3::GFP              *arl-13;klp-11*   0.97/0.19   242/16   P \< 0.001   1.04/0.17   63/4     P \< 0.001
  KAP-1::GFP              N2                0.69/0.11   92/9                  ND          ND       
  KAP-1::GFP              *arl-13*          0.51/0.13   168/35   P \< 0.001   ND          ND       ND
  DYF-1::GFP              N2                0.67/0.29   189/9                 1.12/0.22   71/6     
  DYF-1::GFP              *arl-13*          0.68/0.24   107/5    P = 0.44     0.98/0.25   60/6     P \< 0.001
  CHE-13::GFP             N2                0.72/0.14   114/7                 1.11/0.24   93/8     
  CHE-13::GFP             *arl-13*          0.54/0.18   262/10   P \< 0.001   0.92/0.30   62/4     P \< 0.001
  CHE-13::mCherry(low)    N2                0.73/0.10   73/10                 1.17/0.22   54/9     
  CHE-13::mCherry(low)    *arl-13*          0.72/0.22   106/15   P = 0.47     1.02/0.21   58/13    P \< 0.001
  CHE-13::mCherry(high)   N2                0.73/0.16   79/3                  1.21/0.23   33/2     
  CHE-13::mCherry(high)   *arl-13*          0.55/0.14   69/11    P \< 0.001   0.91/0.15   20/3     P \< 0.001
  OSM-6::GFP              N2                0.75/0.14   137/7                 1.15/0.21   59/4     
  OSM-6::GFP              *arl-13*          0.53/0.11   291/19   P \< 0.001   0.94/0.29   55/4     P \< 0.001
  CHE-2::GFP              N2                0.71/0.19   156/6                 1.17/0.24   68/5     
  CHE-2::GFP              *arl-13*          0.68/0.15   120/6    P = 0.047    0.93/0.21   48/5     P \< 0.001
  DYF-2::GFP              N2                0.75/0.14   173/11                1.08/0.19   62/4     
  DYF-2::GFP              *arl-13*          0.53/0.15   90/6     P \< 0.001   0.83/0.15   66/4     P \< 0.001
  CHE-11::GFP             N2                0.69/0.19   116/11                1.19/0.28   67/6     
  CHE-11::GFP             *arl-13*          0.66/0.28   120/7    P = 0.15     0.86/0.39   63/5     P \< 0.001
  CHE-11::GFP             *arl-13;osm-3*    0.52/0.08   109/6    P \< 0.001   ND          None     ND
  IFTA-1::GFP             N2                0.69/0.15   94/4                  1.14/0.25   73/4     
  IFTA-1::GFP             *arl-13*          0.68/0.16   127/6    P = 0.35     1.06/0.27   83/8     P = 0.04
  BBS-7::GFP              N2                0.70/0.17   100/4                 1.11/0.25   64/4     
  BBS-7::GFP              *arl-13*          0.55/0.15   241/11   P \< 0.001   0.97/0.28   48/6     P \< 0.001

n, number of particles; N, number of amphids. Mean MS and DS speeds along amphid channel cilia in N2 and *arl-13(tm2322)* worms expressing the indicated transgene are shown. *t* test indicates the pairwise comparison with N2 controls. Blank cells indicate that the information is not applicable.

In DSs, all examined transgenic *arl-13* strains exhibited accelerated IFT at mean speeds of 0.95 µms^−1^ (0.83--1.06 µms^−1^; Fig. S2 and [Table I](#tbl1){ref-type="table"}), indicating that although IFT protein overexpression can dislodge OSM-3 from MS assemblies, OSM-3 still docks with IFT proteins and drives DS IFT. However, the mean DS speed of 0.95 µms^−1^ in *arl-13* worms represents a ∼17% reduction compared with WT worms (∼1.15 µms^−1^). As OSM-3::GFP also moved along MSs/DSs at slower rates (0.97/1.04 µms^−1^) in *klp-11;arl-13* worms, we conclude that OSM-3 speed is slightly reduced in *arl-13* worms ([Table I](#tbl1){ref-type="table"}).

Finally, we examined the IFT transgene overexpression phenotype further by expressing a *che-13::mCherry* transgene at two different levels in *tm2322* worms. To make these strains, gonadal transformation of the *che-13* construct (via microinjection) was conducted at 1× (low) and 5× (high) concentrations. *che-13(high)* induced a SynDyf phenotype in *tm2322* worms, whereas *che-13(low)* did not ([Fig. 6 B](#fig6){ref-type="fig"} and [Table S1](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1)). Also, CHE-13 translocated at slow MS speeds (0.55 µms^−1^) in *che-13(high)*--expressing *arl-13* worms, whereas mean MS speeds were normal (0.72 µms^−1^) in *che-13(low)*--expressing *arl-13* worms (Fig. S3 and [Table I](#tbl1){ref-type="table"}). However, like *osm-3::gfp*--expressing *arl-13* worms, more fast moving MS particles were observed in *che-13(low)*--expressing *arl-13* worms compared with WT controls, and DS speeds were reduced (Fig. S3 and [Table I](#tbl1){ref-type="table"}). From this data, we conclude that the severity of IFT defect in *arl-13* worms depends on IFT transgene expression levels.

In summary, *arl-13* is not required for IFT protein ciliary targeting. Instead, *tm2322* worms possess modestly reduced DS rates and subtle alterations in MS rate profiles and are sensitive to overexpression of IFT transgenes (enhanced cilium morphology and MS IFT defects). Together, these data indicate that *tm2322* possesses IFT defects and suggest that *arl-13* stabilizes anterograde IFT.

*arl-13* interacts genetically with ciliary transport--associated genes to maintain cilium structure/morphology and anterograde IFT
-----------------------------------------------------------------------------------------------------------------------------------

Destabilized IFT, cilium structure/morphology defects, and abnormalities in ciliary transmembrane protein localizations are found in other ciliopathy and ciliary transport--associated *C. elegans* mutants, including *bbs-1/7/8*, *nph-4*, and *dyf-5*, as well as *klp-11* and *osm-3* ([@bib5]; [@bib47]; [@bib34]; [@bib9]; [@bib49]; [@bib29]). Also, because these genes are coexpressed with *arl-13* in most/all *C. elegans* ciliated cells and encode ciliary proteins, Arl13b function appears related to these genes. To address this notion further, double mutant phenotypic analysis was used to assess genetic relationships.

First, we used dye filling to assess cilium structure/morphology and found that compared with single mutants of *arl-13* (moderate Dyf), *klp-11* (not Dyf), *nph-4* (weak Dyf), and *bbs-8* (strong Dyf), *arl-13;nph-4*, *arl-13;klp-11*, and *arl-13;bbs-8* worms were SynDyf ([Fig. 7 A](#fig7){ref-type="fig"}). In agreement with the SynDyf data, *arl-13;klp-11* and *arl-13;nph-4* animals possessed shorter cilia than single mutants ([Fig. 7, B and C](#fig7){ref-type="fig"}), and *arl-13;klp-11* and *arl-13;bbs-8* cilia exhibited specific cilium morphology defects that were worse (e.g., larger bulges) and/or observed more frequently than in single mutants ([Fig. 7, B and C](#fig7){ref-type="fig"}). Enhanced cilium morphology defects were also found in *arl-13;dyf-5* (shorter cilia; very large and more frequent bulges), *arl-13;osm-3* (more frequent kinks), and *arl-13;che-11* (more frequent bulges) worms ([Fig. 7, B and C](#fig7){ref-type="fig"}). Together, these data show that *arl-13* interacts genetically with ciliopathy/ciliary transport genes. Finally, using KAP-1::GFP and DYF-2::GFP markers, we assessed anterograde IFT in *arl-13;dyf-5* and *arl-13;bbs-8* animals. In *arl-13*, *bbs-8*, and *dyf-5* single mutants, moving IFT particles were clearly observable, although particle frequency (DYF-2 marked) may have been slightly reduced in *bbs-8* and *arl-13* animals ([Fig. 7, D--G](#fig7){ref-type="fig"}; [Table I](#tbl1){ref-type="table"}; and [Videos 1--5](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1)). However, in *arl-13;dyf-5* double mutants, kymographs frequently failed to detect moving particles ([Fig. 7, D and E](#fig7){ref-type="fig"}; and [Videos 6 and 7](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1)), and in those ciliary bunches where moving particles were detectable, particle frequently was severely reduced ([Fig. 7 F](#fig7){ref-type="fig"} and [Video 8](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1)). Although not to same extent as *arl-13;dyf-5* mutants, IFT particle number also appeared reduced in some *arl-13;bbs-8* worms ([Fig. 7, E and G](#fig7){ref-type="fig"}; and [Videos 9 and 10](http://www.jcb.org/cgi/content/full/jcb.200908133/DC1)).

![***arl-13* interacts synthetically with ciliopathy/ciliary transport genes to maintain cilium structure/morphology and IFT.** (A) Compared with single mutants, *arl-13;klp-11*, *arl-13;bbs-8*, and *arl-13;nph-4* mutants are SynDyf, failing to take up dye. Merged DIC--fluorescence head images from single and double mutants after a DiI uptake assay (arrows denote dye uptake) are shown. (B and C) PHA/B cilia morphology defects are enhanced in double mutants of *arl-13* and ciliopathy/ciliary transport genes. B shows cilium morphology data from worms expressing a PHA/B cilium marker (*srb-6p::gfp*). Data for kinks/bulges represent the percentage of cilia with these defects. n, number of animals assayed for cilium length; N, number of cilia assessed for ciliary kinks/bulges; N\*, number of cilia assessed for bulges. C shows fluorescence images of PHA/B cilia in single and double mutants. Arrowheads indicate axonemal bulges, and asterisks indicate the cilia base. (D) Anterograde IFT particle formation (marked by KAP-1::GFP and DYF-2::GFP) is defective in *arl-13;dyf-5* double mutants compared with single mutants. Fluorescence images, kymographs, and kymograph schematics of single and double mutants expressing *kap-1::gfp* or *dyf-2::gfp* are shown. (E--G) Quantitative analysis of anterograde IFT kymographs (from animals expressing *dyf-2::gfp*). Unlike single mutants, in many *arl-13;dyf-5* double mutants, moving IFT assemblies are not found (E) or are severely reduced in number (F). Fewer moving IFT particles also found in *arl-13;bbs-8* double mutants compared with single mutants (G). (F and G) Error bars indicate SEM. Bars: (A) 10 µm; (C) 3 µm; (D) 2 µm.](JCB_200908133_RGB_Fig7){#fig7}

Together, our analyses demonstrate that *arl-13* interacts genetically with IFT-related genes to maintain cilium structure/morphology and, in the case of *bbs-8* and *dyf-5*, the integrity of the IFT system. Because the ciliary localization of ARL-13 is distinct from other ciliopathy/ciliary transport--associated genes proteins and because ARL-13 does not undergo IFT-like motility, the additive/cooperative nature of these interactions may reflect a distinct function for *arl-13* within a parallel/converging pathway.

Discussion
==========

In this study, we show that JS-associated Arl13b is a ciliary membrane--associated protein required to maintain *C. elegans* cilium structure/morphology and ciliary protein transport processes, including anterograde IFT stability and the ciliary localizations/abundance of transmembrane proteins. In addition, we show that *arl-13* functions additively with other ciliopathy/ciliary transport genes to maintain cilium structure/morphology and IFT.

ARL-13/Arl13b associates with the ciliary membrane via palmitoyl anchors
------------------------------------------------------------------------

Several our findings indicate that ARL-13/Arl13b associates with ciliary membranes: (a) Arl13b is palmitoylated, (b) Pal modification motif disruption causes ARL-13/Arl13b to delocalize in a cytosolic/diffuse fashion, (c) Arl13b cofractionates with membrane proteins, whereas Arl13b(C8S/C9S) variants cofractionate with cytosolic proteins, (d) ARL-13 and Arl13b proteins reside exclusively in cilia ([@bib6]; [@bib11]; [@bib10]; [@bib25]), and (e) ARL-13 localizes to AWB cilia membrane fans. Arl13b joins other ciliopathy/ciliogenic proteins thought to associate with membranes, including BBSome components ([@bib31]), Meckel syndrome/JS proteins with membrane-targeting C2 domains (MKS-1, MKSR-1, MKS-6, and RPGRIP1L), RAB8 ([@bib31]; [@bib53]), and Elipsa ([@bib32]). However, Arl13b is unique as it localizes exclusively to cilia.

Localization of ARL-13/Arl13b to a distinct proximal ciliary compartment
------------------------------------------------------------------------

Our finding that ARL-13/Arl13b localizes predominantly to the proximal ciliary region of most *C. elegans* sensory cilia and MDCKII cilia ([Fig. 1, A and B](#fig1){ref-type="fig"}) contrasts with *C. elegans* AWB cilia and other mammalian cell types, in which ARL-13/Arl13b localizes along the entire axoneme ([@bib11]; [@bib10]; [@bib25]). Thus, Arl13b appears largely excluded from distal regions of some ciliary subtypes. Intriguingly, the ciliopathy-associated Inv protein (Inversin) also localizes to the proximal region or Inv compartment of mammalian renal tubule epithelial cells ([@bib46]). Conversely, Arl13b localization in mouse renal cilia was not restricted to the Inv compartment but observed along the entire cilium length (Shiba, D., and T. Yokoyama, personal communication). Although the mechanism of ARL-13/Arl13b DS exclusion in certain ciliary subtypes is not known, one possibility is that it may have an MT basis. For example, in *C. elegans* amphid/phasmid channel cilia, MSs contain doublet MTs, whereas DSs consist of singlet MTs ([@bib39]). However, as ARL-13 localizes to AWB cilia membrane fans, which lack MTs altogether, a correlation between MTs and restriction of ARL-13/Arl13b to discrete ciliary regions is unlikely. Instead, the answer may be related to regional differences in ciliary membrane lipid/protein compositions.

ARL-13/Arl13b and cilium formation
----------------------------------

*C. elegans* ARL-13 is not required for building *C. elegans* sensory cilia but is required for cilium structure/morphology. This is likely true for most, if not all, nematode cilia because *arl-13* is expressed in most/all ciliated cells ([@bib19]) and is required for normal cilium morphology of all examined ciliary subtypes ([Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}). The morphological/ultrastructural phenotypes of *arl-13* worms are consistent with Arl13b mutant mice (*hnn*), which possess truncated nodal cilia and open B-tubules ([@bib11]). However, axonemal bulges were not reported in *hnn* mice, indicating that this phenotype is specific to worms or restricted to cilia subtypes. Interestingly, abnormal ciliary bulges and axonemal vesicles were found in motile cilia of *BBS1*, -*2*, and -*4* mice ([@bib45]), and abnormal dense matrix--filled vesicles were described in *C. elegans* IFT mutants (*che-11* and *osm-5*; [@bib39]). These findings suggest that *arl-13* overlaps functionally with other ciliopathy/ciliary transport--associated genes and that vesicle accumulation in ciliary axonemes may be a feature of ciliopathies. Because vesicles are not found in WT cilia, what is their origin? It seems unlikely that they originate from aberrant entry into cilia because transition zones are intact in *arl-13* animals ([Fig. 4](#fig4){ref-type="fig"}), indicating that the physical block to vesicles is maintained. Instead, vesicles may originate from the ciliary membrane and could reflect a specific defect in ciliary membrane processes. The MT defects also raise the possibility of MT-stabilizing functions for *arl-13*. Indeed, unzipped MTs are also reported in *nphp-4* mutants ([@bib29]), and one possible explanation is loss of MT posttranslational modification (e.g., polyglutamylation) such as that in zebrafish *fleer* mutants ([@bib38]).

ARL-13/Arl13b is required for ciliary transport processes
---------------------------------------------------------

Several of our findings indicate that *C. elegans* ARL-13 stabilizes ciliary protein transport. First, ciliary transmembrane proteins abnormally distribute and accumulate within *arl-13* cilia ([Fig. 5](#fig5){ref-type="fig"}). Consistent with these defects being linked to transport deficiencies, similar phenotypes are found in IFT mutants ([@bib2]; [@bib49]). Second, DS IFT rates are reduced in *tm2322* mutants, and overexpression of IFT transgenes disrupts cilium structure/morphology and anterograde IFT, causing OSM-3 to uncouple from MS IFT assemblies ([Fig. 6](#fig6){ref-type="fig"} and [Table I](#tbl1){ref-type="table"}). Third, *arl-13* functions genetically with ciliary transport--associated genes to maintain cilium structure and IFT ([Fig. 7](#fig7){ref-type="fig"}). Interestingly, the *tm2322* allele used in this study is an in-frame deletion, encoding a protein that still localizes to cilia ([Fig. 3 B](#fig3){ref-type="fig"}). Accordingly, ARL-13(tm2322) likely represents a ciliary G protein with deregulated functions.

Our observation that IFT transgene overexpression in *tm2322* mutants leads to SynDyf phenotypes and IFT destabilization has also been reported in *nph-4* mutants ([@bib29]), indicating that this phenomenon is not restricted to *arl-13* and extends to other ciliopathy genes. Also, although not phenotypically identical, kinesin-2 motor decoupling is a feature of other ciliary transport and ciliopathy-associated mutants such as *bbs-1/7/8* and *dyf-5* ([@bib34], [@bib35]; [@bib9]). To explain our MS IFT rate data, we propose that endogenous MS anterograde IFT assemblies are partially destabilized (biochemically) in *arl-13* worms (but still largely intact) and susceptible to further weakening (i.e., OSM-3 dislodgment) by IFT protein overexpression ([Fig. 8, A and B](#fig8){ref-type="fig"}). Consistent with this idea, when expressed at lower levels in *tm2322* animals, a *che-13::mCherry* transgene did not cause a SynDyf phenotype nor a severe IFT defect (e.g., complete motor uncoupling). Regardless, for all IFT proteins examined, some degree of anterograde IFT defect was observed. One possible explanation is that the *tm2322* allele generates a genetic background that disrupts the biochemical properties of IFT assemblies (e.g., macromolecular architecture and subunit stoichiometry), which in turn confers a reduced tolerance for changes in the stoichiometry of certain IFT protein subunits. Indeed, there is evidence in our data that enhanced destabilization correlates with overexpression of IFT-B subunits, suggesting that ARL-13 may preferentially facilitate interactions of IFT-B proteins with IFT assemblies.

![**Model of ARL-13/Arl13b function.** (A) Summary of *arl-13(tm2322)* ciliary phenotypes showing disrupted cilium ultrastructure/morphology and ciliary membrane protein localization and weakly destabilized anterograde IFT assemblies (e.g., reduced DS speeds). (B) Overexpression of IFT transgenes in *tm2322* further destabilizes anterograde IFT assemblies, causing decoupling of OSM-3 and enhancement of cilium structure/morphology defects. OSM-3 retains the ability to dock with IFT/BBS assemblies in DSs. (C) Model of ARL-13/Arl13b function in WT cilia. Arl13b associates with ciliary membranes via palmitoyl anchors, where it regulates the function or functions of unknown effectors required to stabilize ciliary protein transport processes. Effectors may interact directly with transport machinery or, alternatively, regulate ciliary membrane or axonemal MT processes (e.g., membrane biogenesis/turnover or MT stabilization), which indirectly facilitate protein transport.](JCB_200908133_RGB_Fig8){#fig8}

Model of ARL-13/Arl13b function and ciliary protein transport
-------------------------------------------------------------

We propose that ARL-13/Arl13b associates with the ciliary membrane and is required for normal ciliary transport processes ([Fig. 8](#fig8){ref-type="fig"}). Whether ARL-13 regulates transport directly or indirectly is unclear ([Fig. 8 C](#fig8){ref-type="fig"}). Our analyses reveal multiple structural and functional ciliary requirements for ARL-13 at the ciliary membrane, MTs, and protein transport. Pinpointing the primary defect is difficult because of the nonautonomous nature of these processes and structures. For example, as IFT assemblies contact MTs and membranes, defects in either could indirectly disrupt ciliary transport or vice versa ([Fig. 8 C](#fig8){ref-type="fig"}). However, an exclusive role in regulating ciliary transport seems less likely because (a) *arl-13* interacts genetically with IFT genes, (b) ARL-13 does not undergo IFT, and (c) ARL-13 localizes to ciliary regions that lack MTs (e.g., AWB cilia membrane fans). In contrast, because ARL-13 associates with membranes and is required for proper cilium shape, a role for *arl-13* in regulating ciliary membranes seems more likely. Therefore, the IFT connection may be indirect and simply arise because IFT assemblies contact ciliary membranes. Indeed, membrane-associated functions such as lipid metabolism, membrane curvature, and membrane remodeling are known for numerous small G proteins, and it is well established that G proteins function at membrane surfaces ([@bib15]; [@bib3]). Future work in identifying Arl13b binding partners/effectors should provide clues to the role of Arl13b at ciliary membranes and how it affects protein transport.

Arl13b, Shh signaling, and JS
-----------------------------

Our findings for ARL-13 suggest that mammalian Arl13b may also facilitate ciliary protein transport. Indeed, this is consistent with the role of *Arl13b*/*hnn* in Shh signaling, where it functions downstream of Smo/Ptch1 and upstream of Gli ([@bib11]), which is precisely where IFT functions ([@bib26]; [@bib18]). Indeed, Gli activity is not altogether lost in *hnn* mutants (unlike IFT mutants; [@bib11]; [@bib18]), which is consistent with our worm data showing that IFT still operates in *arl-13* animals. Because ciliary transmembrane protein localizations and levels are disrupted in *arl-13* mutants, it is tempting to speculate that the ciliary localizations of Shh components are defective in *hnn* mice. If so, this would provide a mechanistic basis for the Shh signaling abnormalities in these animals and provide a working model showing that defects in the transport/localizations of developmental signaling proteins underlie Arl13b-associated JS.

Materials and methods
=====================

*C. elegans* strains
--------------------

All nematode strains were maintained and cultured at 20°C using standard techniques ([@bib8]). Nontransgenic strains are as follows: Bristol, *N2*; 2322, *arl-13(tm2322)*; PR802, *osm-3(p802)*; VC1228, *klp-11(tm324)*; PR813, *osm-5(p813)*; CB1033, *che-2(e1033)*; CB3330, *che-11(e1810)*; MX52, *bbs-8(nx77)*; and RB1146, *dyf-5(ok1170)*, *nph-4(tm925);him-5(e1490)*, and *pkd-2(sy606);him-5(e1490)*.

Transgenic strains expressing ARL-13(WT)::GFP and ARL-13::GFP variants are as follows: OEB223, *N2;oqEx58\[arl-13::gfp+pRF4\]*; OEB161, *arl-13(tm2322);oqEx58\[arl-13::gfp+pRF4\]*; OEB97, *N2;oqEx52\[arl-13(delPal)::gfp+pRF4\]*; OEB96, *N2;oqEx51\[arl-13(rPal)::gfp+pRF4\]*; and OEB99, *N2;oqEx55\[arl-13(del203--370)::gfp+pRF4\]*.

Transgenic strains expressing ciliated cell--specific transcriptional GFP markers are as follows: *N2;gmIs13\[srb-6p::gfp+pRF4\]*; CX3553, *kyIs104\[str-1p::gfp\]*; CX3695, *lin-15;kyIs136\[str-2p::gfp+lin-15(+)\]*; OH3192, *kyIs164\[gcy-5p::gfp\]* and *pkIs519\[gpa-6p::gfp\]*; OEB141, *arl-13(tm2322);gmIs13\[srb-6p::gfp+pRF4\]*; OEB49, *arl-13(tm2322);klp-11(tm324);gmIs13\[srb-6p::gfp+pRF4\]*; OEB224, *arl-13(tm2322);osm-3(p802);gmIs13\[srb-6p::gfp+pRF4\]*; OEB174, *arl-13(tm2322);che-11(e1810);gmIs13\[srb-6p::gfp+pRF4\]*; OEB51, *arl-13(tm2322);bbs-8(nx77);gmIs13\[srb-6p::gfp+pRF4\]*; OEB89, *arl-13(tm2322);nph-4(tm925);gmIs13\[srb-6p::gfp+pRF4\]*; OEB338, *nph-4(tm925);gmIs13\[srb-6p::gfp+pRF4\]*; OEB324, *arl-13(tm2322);dyf-5(ok1170);gmIs13\[srb-6p::gfp+pRF4\]*; OEB339, *dyf-5(ok1170);gmIs13\[srb-6p::gfp+pRF4\]*; OEB53, *arl-13(tm2322);kyIs164\[gcy-5p::gfp\]*; OEB180, *arl-13(tm2322);kyIs104\[str-1p::gfp\]*; OEB61, *arl-13(tm2322);kyIs136\[str-2p::gfp+lin-15(+)\]*; and OEB210, *arl-13;pkIs519\[gpa-6p::gfp\]*.

Transgenic strains expressing GFP-tagged ciliary membrane protein markers are as follows: CX3260, *kyIs53\[odr-10::gfp\]*; CX3716, *kyIs141\[osm-9::gfp+lin-15(+)\]* and *kyIs\[tax-2::gfp+lin-15(+)\]*; PT572, *myIs1\[PKD-2::GFP+unc-122p::GFP\]* (gift from M. Barr, Rutgers University, Piscataway, NJ); OEB152, *arl-13(tm2322);kyIs53\[odr-10::gfp\]*; OEB175, *arl-13;kyIs141\[osm-9::gfp+lin-15(+)\]*; OEB177, *arl-13(tm2322);kyIs111\[tax-2::gfp\]*; and OEB289, *arl-13;myIs1\[PKD-2::GFP;unc-122p::GFP\]*.

Transgenic strains expressing IFT::GFP markers are as follows: MX255, *N2;ejEx\[osm-3::gfp+pRF4\]* (gift from J. Scholey, University of California, Davis, Davis, CA), *N2;ejEx\[kap-1::gfp+pRF4\]* (gift from J. Scholey), *xbx-1(ok279);Ex\[xbx-1::gfp+pRF4\]*, *N2;yhEx\[che-13::gfp+pRF4\]*, and *N2;Ex\[che-12p::che-13::mcherry+unc-122p::gfp\]* (gift from S. Shaham, The Rockefeller University, New York, NY); PT47, *N2;myEx\[che-2::gfp+pRF4\]*, *N2;ejEx\[dyf-1::gfp+pRF4\]* (gift from G. Jansen, Erasmus Medical Center, Rotterdam, Netherlands), *N2;ofEx46\[dyf-2::gfp+pRF4\]*, and *N2;myEx10\[che-11::gfp+pRF4\]*; MX231, *N2;nxEx\[ifta-1::gfp+dpy-5(+)\]* (gift from M. Leroux, Simon Fraser University, Burnaby, British Columbia, Canada); MX76, *dpy-5;nxEx25\[bbs-7::gfp+dpy-5(+)\]* (gift from M. Leroux); MX68, *dpy-5;nxEx\[bbs-8::gfp+dpy-5(+)\]* (gift from M. Leroux); OEB134, *arl-13(tm2322);ejEx\[osm-3::gfp+pRF4\]*; OEB284, *arl-13(tm2322);klp-11(tm324);ejEx\[osm-3::gfp+pRF4\]*; OEB248, *klp-11(tm324);ejEx\[osm-3::gfp+pRF4\]*; OEB132, *arl-13;ejEx\[kap-1::gfp+pRF4\]*; OEB110, *arl-13(tm2322);dyf-5(ok1170);ejEx\[kap-1::gfp+pRF4\]*; OEB226, *arl-13(tm2322);bbs-8(nx77);ejEx\[kap-1::gfp+pRF4\]*; OEB133, *arl-13(tm2322);nxEx\[xbx-1::gfp+pRF4\]*; OEB163, *arl-13(tm2322);mnIs17\[osm-6::gfp+unc-36(+)\]*; OEB159, *arl-13(tm2322);yhEx\[che-13::gfp+pRF4\]*; OEB157, *arl-13(tm2322);myEx\[che-2::gfp+pRF4\]*; OEB160, *arl-13(tm2322);ejEx\[dyf-1::gfp+pRF4\]*; OEB130, *arl-13(tm2322);myEx10\[che-11::gfp+pRF4\]*; OEB117, *arl-13(tm2322);osm-3(p802);myEx10\[che-11::gfp+pRF4\]*; OEB137, *arl-13(tm2322);nxEx\[ifta-1::gfp+dpy-5(+)\]*; OEB135, *arl-13(tm2322);nxEx25\[bbs-7::gfp+dpy-5(+)\]*; OEB136, *arl-13(tm2322);nxEx\[bbs-8::gfp+dpy-5(+)\]*; OEB156, *arl-13(tm2322);ofEx46\[dyf-2::gfp+pRF4\]*; OEB95, *arl-13(tm2322);klp-11(tm324);ofEx46\[dyf-2::gfp+pRF4\]*; OEB227, *arl-13(tm2322);dyf-5(ok1170);ofEx46\[dyf-2::gfp+pRF4\]*; and OEB115, *arl-13(tm2322);bbs-8(nx77);ofEx46\[dyf-2::gfp+pRF4\]* and *bbs-8(nx77);ofEx46\[dyf-2::gfp+pRF4\]*.

Genetic crossing
----------------

Standard genetic crossing techniques were used to make double mutants and to introduce transgenes into various genetic backgrounds. PCR using primers that flank deletions were used to follow the *arl-13(tm2322)*, *klp-11(tm324)*, *bbs-8(nx77)*, and *nph-4(tm925)* deletion mutations. All other mutations were followed using the dye-filling assay.

Generation of *arl-13::gfp* constructs
--------------------------------------

All translational *arl-13::gfp* constructs (WT and variant) were generated using fusion PCR as previously described ([@bib24]). For the *arl-13(WT)* reporter, a genomic DNA fragment containing 300 bp of 5′ untranslated region (promoter) plus the entire exonic and intronic sequence of *arl-13* was fused in frame with *gfp*. Similarly, for the C-terminal truncation variant (del203--370), *gfp* was fused in frame with genomic DNA fragments containing 300 bp of *arl-13* 5′ untranslated region plus exonic/intronic *arl-13* sequence (nucleotides 1--2701 of *arl-13* genomic sequence). For the Pal motif variants (delPal, deletion of C12--C15; and rPal, replacement of C12--C15 with ASAS), two fusion reactions were performed. In the first reaction, PCR fragments containing the *arl-13* promotor (214 bp) plus 33 bp of exon 1 were fused to nucleotides 34--3300 of *arl-13*, where nucleotides 34--45 (TGCTGTTGTTGC) were altered by primer design to (TCCGCTTCTGCC; rPal) or deleted altogether (delPal). Resulting PCR products were subsequently fused in frame with *gfp*. All constructs were coinjected at 1--10 ng/µl with 50 ng/µl pRF4 into N2 worms to generate roller transgenic animals harboring *arl-13::gfp* (WT and variant) extrachromosomal arrays.

Dye-filling assay
-----------------

Worms were placed in 200 µl of DiI (or DiO) solution (Invitrogen; diluted 1:200 with M9 buffer). After 1-h incubation, worms were recovered on seeded nematode growth medium plates for a further hour and then mounted on slides. Epifluorescence wide-field imaging under red (DiI) or green filters (DiO) was used to image DiI/DiO uptake into ciliated amphid/phasmid cells.

Chemosensory behavioral assays
------------------------------

Chemotaxis assay toward isoamyl alcohol was performed on 85-mm round plates. 1 µl of 1 M NaN3 (anesthetic) was applied to two points at opposite ends of the plate (5 mm from the edge). Then, 1 µl of attractant (diluted 1:100 in 95% ethanol) was spotted at one of these points, and 1 µl of ethanol was spotted at the other as a control. Young adult worms (∼100), washed three times with M9 buffer and once with deionized water, were then applied to plate center (∼3.5 cm from attractant). After excess liquid removal, worms were allowed to partition across the plate for 30 and 60 min. The chemotaxis index was calculated at each time point as (*a* − *b*)/*n*, where *a* equals the number of worms within 1.5 cm of the attractant, *b* equals the number of worms within 1.5 cm of the ethanol counterattractant, and *n* equals the total number of worms in the assay.

Electron microscopy
-------------------

Worms were washed directly into a primary fixative of 2.5% glutaraldehyde in 0.1 M Sorensen phosphate buffer. To facilitate rapid ingress of fixative, worms were cut in half using a razor blade under a dissection microscope, transferred to Eppendorf tubes, and fixed for 1 h at room temperature. Samples were then centrifuged at 3,000 rpm for 2 min, and supernatant was removed and washed for 10 min in 0.1 M Sorensen phosphate buffer. The worms were then postfixed in 1% osmium tetroxide in 0.1 M Sorensen phosphate buffer for 1 h at room temperature. After washing in buffer, specimens were processed for electron microscopy by standard methods; in brief, they were dehydrated in ascending grades of alcohol to 100% infiltrated with epon and placed in aluminum planchettes orientated in a longitudinal aspect and polymerized at 60°C for 24 h. Using an ultramicrotome (UC6; Leica), individual worms were sectioned in cross section, from anterior tip, at 1 µm until the area of interest was located, as judged by examining the sections stained with toluidine blue by light microscopy. Thereafter, serial ultrathin sections of 80 nm were taken for electron microscopical examination. These were picked up onto 100-mesh copper grids and stained with uranyl acetate and lead citrate. Using an electron microscope (Tecnai Twin; FEI), sections were examined to locate, in the first instance, the most distal region of the ciliary region and subsequently from that point to the more proximal regions of the ciliary apparatus. At each strategic point, DSs, MSs, and transition zone/fiber regions were tilted using the Compustage of the Tecnai to ensure that the axonemal MTs were imaged in an exact geometrical normalcy to the imaging system. All images were recorded at an accelerating voltage (120 kV) and objective aperture of 10 µm using a MegaView 3 digital recording system (Olympus).

*C. elegans* fluorescence microscopy and IFT motility assays
------------------------------------------------------------

Worms were anesthetized in 10 mM levamisole and mounted on 2% agarose pads for analysis on a microscope (DM5000B; Leica), fitted with epifluorescence, and a 1.4 NA 100× Plan-Apochromat lens. Images were captured using an electron-multiplying charge-coupled device camera (DV885; Andor Technology) and iQ2.0 software (Andor Technology). iQ2.0 was also used to measure signal intensities of PKD-2::GFP in the cell body and cilia of N2 and *arl-13(tm2322)* mutants. The region of interest was always of identical size, and background signals were subtracted to normalize values. For IFT motility assays, time-lapse videos of IFT along amphid and phasmid cilia were taken no more than 30--45 min after slide preparation, and in each case, the same exposure times (300 ms), gain, and frame rate (3 frames/s) were used. Resulting stacked multi tiff images were processed into kymographs using the multiple kymograph plug-in of ImageJ 1.38× software (National Institutes of Health; <http://www.embl-heidelberg.de/eamnet/html/body_kymograph.html>). Particle velocities were determined from the kymographs using the ImageJ "read velocities from tsp" macro. The frequency of IFT particles was also determined from the kymographs by counting the number of lines detected.

Mammalian cell culture and immunofluorescence microscopy
--------------------------------------------------------

MDCKII cells were cultured on a coverglass (15-mm diameter) in DME supplemented with 10% (vol/vol) fetal bovine serum for 7 d after full confluence, with the medium changed every 3 d. RPE1 cells were transiently transfected with Arl13b-GFP expression vectors using Fugene6 (Roche) and cultured for 48 h in a starvation medium consisting of DME/F12\[1:1\] (Invitrogen) and 0.1% (wt/vol) BSA. For immunofluorescence staining, cells were fixed with 4% paraformaldehyde in PBS for 10 min, followed by incubation with ice-cold methanol for 5 min. After permeabilization with 0.2% Triton X-100 in PBS for 10 min, cells were treated with 5% BSA in TBS (TBS/5% BSA) and further incubated with primary antibodies in TBS/5% BSA at 37°C for 2 h. Cells were then washed three times with PBS and incubated with an Alexa Fluor 488/568--conjugated secondary antibody (Invitrogen) and DAPI for 30 min in TBS/5% BSA. After washing three times with PBS, the coverglass was mounted onto a glass slide in Permafluor mounting medium (Immunon) and viewed under a confocal microscope (LSM 510; Carl Zeiss, Inc.). The rabbit anti-Arl13b polyclonal antibody was described previously ([@bib25]). Anti--acetylated tubulin, anti--γ-tubulin, and anti-Flag M2 antibodies were purchased from Sigma-Aldrich.

Subcellular fractionation and immunoblotting
--------------------------------------------

293T cells cultured on a 10-cm dish (∼70% confluent) were transfected with 8 µg of expression vectors encoding WT or mutant versions of Arl13b (Flag tagged) using Lipofectamine 2000 (Invitrogen). 2 d after transfection, cells were washed twice with ice-cold wash buffer (10 mM triethanolamine--acetic acid, pH 7.6, and 250 mM sucrose) and suspended to 1 ml of ice-cold homogenization buffer (10 mM triethanolamine--acetic acid, pH 7.6, 250 mM sucrose, 5 mM MgSO~4~, 1 mM DTT, and 2 µg/ml aprotinin). The cell suspension was homogenized by 10 strokes in a chilled cell homogenizer with a tungsten-carbide ball (clearance of 10 µm; Isobiotec) and then subjected to standard subcellular fractionation by centrifugation ([@bib23]), followed by immunoblotting with anti-Flag M2, anti--µ-calpain (\#MA3-940; Thermo Fisher Scientific), and anti-Na^+^/K^+^ ATPase α-1 (Millipore) antibodies.

Metabolic labeling with \[^3^H\]palmitic acid and fluorography
--------------------------------------------------------------

Palmitoylated proteins were detected as described previously ([@bib21]; [@bib50]). 293T cells cultured on a 6-well dish (∼70% confluent) were transfected with 3 µg of expression vectors encoding WT or mutant versions of human GFP-tagged Arl13b using Lipofectamine 2000. 2 d after transfection, the cells were preincubated for 30 min in serum-free DME supplemented with 0.1% fatty acid--free BSA (Sigma-Aldrich). The cells were then metabolically labeled for 4 h with serum-free DME containing 0.25 mCi/ml \[^3^H\]palmitate (PerkinElmer). After washing twice with ice-cold PBS, the cells were extracted with 100 µl of ice-cold extraction buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1% NP-40, 5 mM MgCl~2~, 1 mM DTT, 2 µg/ml aprotinin, and 2 µg/ml leupeptin). After centrifugation at 20,000 *g* for 20 min, the supernatants were subjected to SDS-PAGE. After fixing the gels for 30 min in a fixing solution (methanol/acetic acid/water, 3:1:6), the gels were treated with Amplify fluorographic reagent (GE Healthcare) for 30 min, dried under vacuum, and exposed to the x-ray film (RX-U; Fujifilm) without intensifying screen at −80°C for 72 h. The supernatants were also subjected to Western blot analysis with anti-GFP antibody.

Online supplemental material
----------------------------

Fig. S1 shows that *C. elegans* ARL-13 is a sequence homologue of human JS-associated Arl13b. Fig. S2 shows that overexpression of *arl-13(delPal)* in N2 worms does not disrupt PKD-2 ciliary abundance. Fig. S3 shows anterograde rate profiles of various IFT proteins along the MSs of *arl-13(tm2322)* mutants. Videos 1--10 show time-lapse recordings of KAP-1::GFP in amphid/phasmid channel cilia of *arl-13* (Video 1), *dyf-5* (Video 3), and *arl-13;dyf-5* (Video 6) and DYF-2::GFP in amphid/phasmid channel cilia of *arl-13* (Video 2), *dyf-5* (Video 4), *bbs-8* (Video 5), *arl-13;dyf-5* (Videos 7 and 8), and *arl-13;bbs-8* (Videos 9 and 10). Table S1 shows that overexpression of high levels but not low levels of a *che-13::mCherry* transgene enhances the Dyf defect of *arl-13* mutants. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200908133/DC1>.
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